Classification of diabetic retinopathy and diabetic macular edema.

The global incidence and prevalence of diabetes mellitus (DM) have reached epidemic proportions. Estimates indicate that more than 360 million people will be affected by DM by 2030. All of these individuals will be at risk of developing diabetic retinopathy (DR). It is extremely important to categorize, classify and stage the severity of DR in order to establish adequate therapy. With proper management more than 90% of cases of visual loss can be prevented. The purpose of the current paper is to review the classification of DR with a special emphasis on the International Clinical Disease Severity Scale for DR. This new classification is simple to use, easy to remember and based on scientific evidence. It does not require specialized examinations such as optical coherence tomography or fluorescein angiography. It is based on clinical examination and applying the Early Treatment of Diabetic Retinopathy Study 4:2:1 rule.

[1]  N. Bressler,et al.  Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results. , 2015, Ophthalmology.

[2]  L. Aiello,et al.  Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. , 2012, Ophthalmology.

[3]  G. Casazza,et al.  Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. , 2011, The Cochrane database of systematic reviews.

[4]  R. Bernardes,et al.  Central retinal thickness measured with HD-OCT shows a weak correlation with visual acuity in eyes with CSME , 2010, British Journal of Ophthalmology.

[5]  Ingrid U Scott,et al.  Diabetic macular edema: what is focal and what is diffuse? , 2008, American journal of ophthalmology.

[6]  M. Khairallah,et al.  Diabetic Macular Edema. An OCT-Based Classification , 2008 .

[7]  Peter K Kaiser,et al.  Optical coherence tomographic patterns of diabetic macular edema. , 2006, American journal of ophthalmology.

[8]  D. Browning,et al.  Regional patterns of sight-threatening diabetic macular edema. , 2005, American journal of ophthalmology.

[9]  J. Forrester,et al.  Epidemiology of diabetic retinopathy and macular oedema: a systematic review , 2004, Eye.

[10]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[11]  E. Gusson,et al.  Diabetic macular edema: an OCT-based classification , 2004, Seminars in ophthalmology.

[12]  E. Chew.  Guest editorial: a simplified diabetic retinopathy scale , 2003 .

[13]  E. Chew.  A simplified diabetic retinopathy scale. , 2003, Ophthalmology (Rochester, Minn.).

[14]  G. Brown,et al.  Utility values and diabetic retinopathy. , 1999, American journal of ophthalmology.

[15]  F. Ferris.  Early photocoagulation in patients with either type I or type II diabetes. , 1997, Transactions of the American Ophthalmological Society.

[16]  J. Javitt,et al.  Cost-effectiveness of detecting and treating diabetic retinopathy. , 1996, Annals of internal medicine.

[17]  T. Kern,et al.  Retinopathy in animal models of diabetes. , 1995, Diabetes/metabolism reviews.

[18]  Murphy Rp.  Management of diabetic retinopathy. , 1995 .

[19]  R. Murphy.  Management of diabetic retinopathy. , 1995, American family physician.

[20]  R. Klein,et al.  The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. , 1994, Archives of ophthalmology.

[21]  Lloyd Paul Aiello,et al.  Preventive Eye Care in People With Diabetes Is Cost-Saving to the Federal Government: Implications for health-care reform , 1994, Diabetes Care.

[22]  F. Ferris,et al.  How effective are treatments for diabetic retinopathy? , 1993, JAMA.

[23]  Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Early Treatment Diabetic Retinopathy Study Research Group. , 1991, Ophthalmology.

[24]  M. Goldberg,et al.  Knowledge of diabetic retinopathy before and 18 years after the Airlie House Symposium on Treatment of Diabetic Retinopathy. , 1987, Ophthalmology.

[25]  G. Bresnick,et al.  DIABETIC MACULAR EDEMA: A REVIEW , 1986 .

[26]  R. Klein,et al.  Visual impairment in diabetes. , 1984, Ophthalmology.